Efficacy and safety of anamorelin in patients with cancer cachexia: Post‐hoc subgroup analyses of a placebo‐controlled study

Efficacy and safety of anamorelin in patients with cancer cachexia: Post‐hoc subgroup analyses of a placebo‐controlled study

Abstract Background Cachexia, a disorder associated with anorexia, inflammation, and muscle wasting, is frequent in cancer patients. We performed post‐hoc analyses of the ONO‐7643‐04 study to investigate the efficacy and safety of anamorelin in subgroups of Japanese patients with non‐small cell lung...

Full description

Saved in:
Bibliographic Details
Main Authors: Koichi Takayama, Toru Takiguchi, Naoyuki Komura, Tateaki Naito
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Cancer Medicine
Subjects:
anamorelin
appetite
body weight
cancer cachexia
lean body mass
non‐small cell lung cancer
Online Access:https://doi.org/10.1002/cam4.5206
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cam4.5206

Similar Items